Chronic myelogenous leukemia in blast crisis: Retrospective analysis of prognostic factors in 90 patients

Annals of Hematology

Volumn 73, Issue 5, 1996, Pages 225-230

  Griesshammer, M ^a   Heinze, B ^b   Hellmann, A ^a   Popp, C ^a   Anger, B ^a   Heil, G ^a   Bangerter, M ^a   Heimpel, H ^a  

^a Department of Internal Medicine III ^*  (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Blast crisis; Chronic myelogenous leukemia; Karyotypic findings; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOCYTHEMIA; TRISOMY 8;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLAST CRISIS; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0029802820     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050233     Document Type: Article

References (28)

1. Alimena G, Dallapiccola B, Gastaldi R, Mandelli F, Brandt L, Mitelman F, Nilsson PG (1982) Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukemia. A study of 69 cases. Scand J Haematol 28:103-117
2. Anger B, Carbonell F, Braunger I, Heinze B, Gutensohn W, Thiel E, Heimpel H (1988) Blast crisis of Philadelphia chromosome-positive chronic myelocytic leukemia (CML). Treatment results of 69 patients. Blut 57:131-137
3. Arlin ZA, Silver RT, Bennett JM (1990) Blastic phase of chronic myeloid leukemia: a proposal for standardization of diagnostic and response criteria. Leukemia 4:755-757
4. Carella AM, Gaozza E, Raffo MR, Carlier P, Frassoni F, Valbonesi M, Lercari G, Sessarego M, Defferrari R, Guerrasio A, Saglio G, Canepa L, Gaetani GF, Occhini D (1991) Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporin A. Leukemia 5:517-521
5. Cervantes F, Ballesta F, Milá M, Rozman C (1986) Cytogenetic studies in blast crisis of Ph-positive chronic granulocytic leukemia: results and prognostic evaluation in 52 patients. Cancer Genet Cytogenet 21:239-246
6. Cervantes F, Rozman M, Rosell J, Urbano-Ispizua A, Montserrat E, Rozman C (1990) A study of prognostic factors in blast crisis of Philadelphia chromosome-positive chronic myelogenous leukemia. Br J Haematol 76:27-32
7. Coleman M, Silver RT, Pajak TF, Cavalli F, Rai KR, Kostinas JE, Glidewell O, Holland JF (1980) Combination chemotherapy for terminal phase chronic granulocytic leukemia: cancer and leukemia group B studies. Blood 55:29-36
8. Cox DR (1972) Regression model and life tables. J R Stat Assoc 34:187-220
9. Derderian PM, Kantarjian HM, Talpaz M, O'Brien S, Cork A, Estey E, Pierce S, Keating M (1993) Chronic myelogenous leukemia in the lymphoid blastic phase. Characteristics, treatment response and prognosis. Am J Med 94:69-74
10. Fialkow PJ, Martin PJ, Naifield V, Penfold GK, Jacobson RJ, Hansen JA (1981) Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 58:158-163
11. Heinze B, Arnold R, Kratt E, Bunjes D, Heit W, Fliedner TM (1989) Clonal evolution of chromosomal anomalies in leukemic patients after bone marrow transplantation. In: Chadwick, KH et al (eds) Cell transformation and radiation-induced cancer. Adam Hilger Ltd., Bristol pp 177-184
12. ISCN (1991) Guidelines for cancer cytogenetics, Supplement to: Mitelman F (ed) An International System for Cytogenetic Nomenclature S. Karger, Basel
13. Janossy G, Woodruff RK, Pippard MJ, Prentice G, Hoffbrand AV, Paxton A, Lister TA, Bunch C, Greaves MF (1979) Relation of "lymphoid" phenotype and response to chemotherapy incorporating vincristine-prednisone in the acute phase of Ph+ positive leukemia. Cancer 43:426-434
14. Kantarjian HM, Keating MJ, Talpaz M, Walters DS, Smith TL, Cork A, McCredie KB, Freireich EJ (1987) Chronic myelogenous leukemia in blast crisis: an analysis of 242 patients. Am J Med 83:445-454
15. Kantarjian HM, Dixon D, Keating MJ, Talpaz M, Walters RS, McCredie KB, Freireich EJ (1988) Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer 61:1441-1446
16. Kantarjian HM, Walters RS, Keating MJ, Talpaz M, Andersson B, Beran M, McCredie KB, Freireich EJ (1988) Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine-arabinoside. Cancer 62:672-676
17. Kantarjian HM, Talpaz M, Gutterman J, Kontoviannis D, Keating M, Estey E, O'Brien S, Beran M, Deisseroth A (1991) Treatment of chronic myelogenous leukemia (CML) in accelerated and blastic phases with daunorubicin, high-dose cytosine-arabinoside and granulocyte-macrophage colony-stimulating factor. Blood 78 [Suppl 1]:1810
18. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M (1993) Chronic myelogenous leukemia. A concise update. Blood 82:691-703
19. Kaplan ES, Meier P (1958) Non-parametric estimations from incomplete observations. J Am Stat Assoc 53:457-481
20. Karanas A, Silver RT (1968) Characteristics of the terminal phase of chronic granulocytic leukemia. Blood 32:445-459
21. Keating MJ, Smith TL, McCredie KB, Bodey GP, Hersh EM, Guttermann JU, Gehan E, Freireich EJ (1981) A four-year experience with anthracycline, cytosine arabinoside, vincristine, and prednisone combination in 325 adults with acute leukemia. Cancer 47:2779-2788
22. Nanjangud G, Kadam PR, Saikia T, Bhisey AN, Kumar A, Gopal R, Chopra H, Nair CN, Advani SH (1994) Karyotypic findings as an independent prognostic marker in chronic myeloid leukemia blast crisis. Leuk Res 18:385-392
23. O'Malley FM, Garson OM (1985) Chronic granulocytic leukemia: correlation of blastic transformation type with karyo-type evolution. Am J Hematol 20:313-323
24. Rosenthal S, Canellos GP, Whang-Peng J, Gralnick HR (1977) Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. Am J Med 63:542-547
25. Sadamori N, Gomez GA, Sandberg AA (1983) Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph-positive chronic myeloid leukemia. Blood 61:935-939
26. Sadamori N, Yao E, Mine M, Tokunaga S, Matsunaga M, Nakamura H, Sasagawa I, Itoyama T, Hayashibara T, Sandberg AA (1992) Therapeutic and prognostic value of modal number of chromosomes at the blastic phase of Philadelphia-chromosome-positive chronic myeloid leukemia: comparison based on the same criteria between Nagasaki University and Roswell Park Memorial Institute. Acta Haematol 87:49-53
27. Silver R (1990) Chronic myeloid leukemia - a perspective of the clinical and biologic issues of the chronic phase. Hematol Oncol Clin North Am 4:319-324
28. Visani G, Tosi P, Zinzani PL, Manfroi S, Zaccaria A, Testoni N, Lemoli RM, Rosti G, Pelliconi S, Tura S (1993) FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukemia: a case report. Br J Haematol 86:394-396